FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like 483 Roundup: FDA Cites Firms Over MDRs, CAPAs, History Records December 14, 2017 483 Roundup: FDA Flags 8 Device Firms for Numerous Deficiencies February 15, 2018 Russia Implements New Quality Control Requirements September 16, 2019